Three types of fetal cells can migrate into maternal organs during pregnancy

June 6, 2012

A pregnant woman's blood stream contains not only her own cells, but a small number of her child's, as well, and some of them remain in her internal organs long after the baby is born. Understanding the origin and identity of these cells is vital to understanding their potential effects on a mother's long-term health. For example, fetal cells have been found at tumor sites in mothers, but it is unknown whether the cells are helping to destroy the tumor or to speed its growth.

Three types of have now been identified in the lungs of late-term pregnant mice by a team led by Dr. Diana Bianchi of Tufts Medical Center. The research, published 6 June 2012 in 's Papers-in-Press, used publicly available databases to extract important genetic information from as few as 80 fetal cells. A combination of two different analytical techniques to characterize the rare fetal cells revealed a mixed population of trophoblasts (placental cells that provide nutrients to the fetus), mesenchymal stem cells (cells that later develop into fat, cartilage, or bone cells), and .

Researchers suspect that fetal cells in a mother's blood stream help her immune system tolerate and not attack the fetus. The detection of trophoblasts and immune cells in the maternal lung should aid future studies on this subject, as well as research into pregnancy-related complications like preeclampsia. The presence of fetal corresponds with previous studies that reported fetal and placental cells differentiating to repair injured maternal organs in both mice and humans.

Using this team's techniques of , researchers should now be better able to identify the types of cells present in maternal organs and in doing so determine their potential short- and long-term effects on a mother's internal systems.

Explore further: Fetal stem cells from placenta may help maternal heart recover from injury

More information: Pritchard S, Wick HC, Slonim DK, Johnson KL, Bianchi DW. Comprehensive analysis of genes expressed by rare microchimeric fetal cells in maternal lung. Biol Reprod 2012; (in press). Published online ahead of print 6 June 2012; DOI 10.1095/biolreprod.112.101147

Related Stories

Fetal stem cells from placenta may help maternal heart recover from injury

November 14, 2011
Researchers from Mount Sinai School of Medicine have discovered the therapeutic benefit of fetal stem cells in helping the maternal heart recover after heart attack or other injury. The research, which marks a significant ...

Recommended for you

Using barcodes to trace cell development

August 16, 2017
How do the multiple different cell types in the blood develop? Scientists have been pursuing this question for a long time. According to the classical model, different developmental lines branch out like in a tree. The tree ...

After a half-century of attempts, psilocybin has finally been synthesized in the lab

August 16, 2017
A team of researchers at Friedrich Schiller University Jena has figured how out to make psilocybin, the chemical responsible for creating hallucinations in people who consume the mushrooms that produce it naturally. In their ...

The unexpected role of a well-known gene in creating blood

August 16, 2017
One of the first organ systems to form and function in the embryo is the cardiovascular system: in fact, this developmental process starts so early that scientists still have many unresolved questions on the origin of the ...

Researchers unlock clues to how cells move through the body

August 16, 2017
During its 120-day cycle the circulatory system transports red blood cells and nutrients throughout the human body. This system helps keep the body in balance and fight against infections and diseases by filtering old or ...

Eating habits affect skin's protection against sun

August 15, 2017
Sunbathers may want to avoid midnight snacks before catching some rays.

Therapeutic fusion protein could mitigate blood vessel damage from cardiovascular disease

August 15, 2017
Scientists from Boston Children's Hospital Vascular Biology Program have revealed an engineered fusion protein that could recover blood vessel health following the onset of hypertension, atherosclerosis, stroke, heart attack, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.